semaglutide injections san diego in MEDICAL WEIGHT LOSS GLP1 SEMAGLUTIDE

Ozempic (semaglutide) is FDA approved for Type 2 diabetes and cardiovascular risk reduction and is often prescribed off-label for weight loss

N Engl J Med 384(11):9891002 Davies M, Frch L, Jeppesen OK et al (2021) Semaglutide 24 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial

Patients are encouraged to adopt a balanced diet rich in whole foods, lean proteins, and healthy fats, which can further enhance the medication's efficacy

Hands down one of the greatest group of people I had the pleasure of dealing with